Internal Medicine, Endocrinology, Diabetes, & Metabolism · Orange City, FL
NPI
1700025160
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2777 Enterprise Rd
Orange City, FL, 32763
Phone (386) 774-2550
Groups this clinician bills Medicare through
Medicare paid, 2023
$95K
2,967 services
Medicare patients, 2023
317
Average age 73
Drug cost, 2024
$426K
1,756 prescriptions
Company payments, 2025
$60.52
From 3 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Vladimir K Bakalov was code J0897 (injection, denosumab, 1 mg), 2,280 times for 31 patients. In total Vladimir K Bakalov billed 2,967 services in 16 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,280 | 31 | $18.07 | $41K |
| 99214 Office E&M - Established | Office | 442 | 265 | $91.13 | $40K |
| 99204 Office E&M - New | Office | 66 | 66 | $114.58 | $7,562 |
| 96372 Injection Administration | Office | 38 | 31 | $11.37 | $432 |
| 83036 Blood Count | Office | 35 | 32 | $9.25 | $324 |
| 99213 Office E&M - Established | Office | 32 | 30 | $68.74 | $2,200 |
| 95251 Test - Miscellaneous | Office | 28 | 18 | $26.96 | $755 |
| 82947 Clinical Chemistry | Office | 12 | 11 | $3.85 | $46.2 |
By year: 2022 $111K for 3,422 services; 2023 $95K for 2,967 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 35 | 32 | $9.25 | $324 |
| 82947 Clinical Chemistry | 12 | 11 | $3.85 | $46.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Vladimir K Bakalov prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 257 prescriptions and refills. In total Vladimir K Bakalov wrote 1,756 Medicare prescriptions that cost $426K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 257 | 332 | 63 | $138K |
| Levothyroxine Sodium Generic | 217 | 611 | 101 | $3,053 |
| Insulin Glargine-Yfgn Generic | 138 | 185 | 30 | $12K |
| Novolog Flexpen Insulin Aspart | 116 | 181 | 33 | $19K |
| Metformin Hcl Er Metformin Hcl | 110 | 311 | 55 | $1,877 |
| Metformin Hcl Generic | 81 | 241 | 39 | $1,411 |
| Bydureon Bcise Exenatide Microspheres | 69 | 71 | 19 | $39K |
| Glipizide Er Glipizide | 63 | 175 | 34 | $908 |
| Ultra Thin Pen Needle, Diabetic | 51 | 123 | 29 | $912 |
| Synthroid Levothyroxine Sodium | 47 | 111 | 24 | $5,207 |
| Jardiance Empagliflozin | 44 | 86 | 21 | $48K |
| Insulin Degludec Pen (U-100) Insulin Degludec | 37 | 68 | 12 | $8,012 |
| Ozempic Semaglutide | 34 | 51 | 15 | $45K |
| Glimepiride Generic | 30 | 84 | 11 | $372 |
| Gabapentin Generic | 25 | 57 | 14 | $669 |
Brand drugs: 945 claims; generic drugs: 659 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vladimir K Bakalov $60.52 ($60.52 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $26.93.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.